Failure of Intravenous Silibinin Monotherapy to Prevent Hepatitis C Genotype 2A Liver Graft Reinfection

BACKGROUND: Hepatitis C virus (HCV) recurrence after orthotopic liver transplantation (OLT) remains a serious problem in the clinical management of post-oLT patients. Recently, two case reports have described successful prevention of HCV liver graft reinfection with intravenous silibinin (SIL) monot...

Descripción completa

Detalles Bibliográficos
Autores principales: Aghemo, Alessio, Bhoori, Sherrie, De nicola, Stella, Mazzaferro, Vincenzo, Colombo, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412559/
https://www.ncbi.nlm.nih.gov/pubmed/22879832
http://dx.doi.org/10.5812/hepatmon.6135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3412559/
https://www.ncbi.nlm.nih.gov/pubmed/22879832
http://dx.doi.org/10.5812/hepatmon.6135

Ejemplares similares